At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 20 enrolled
Drug / intervention
itraconazole +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Relative Bioavailability of a Single Oral Dose of BI 691751 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects (an Open-label, Randomised, Two-period, Two-sequence Crossover Study)
In Brief
A Phase 1 clinical trial evaluating itraconazole and BI 691751 for Healthy. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Investigation of the relative bioavailability of a single dose of BI 691751 when given alone and together with itraconazole; safety and tolerability
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--
Timeline
Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
First PostedJan 2014
Primary CompletionMay 2014
TodayJul 2026
First PostedJan 24, 2014
Enrollment StartJan 1, 2014
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 12.4 years ago
Interventions
itraconazoledrug
multiple doses of itraconazole given as capsules
BI 691751drug
single dose BI 691751 given as tablet
BI 691751drug
single dose BI 691751 given as tablet